XML 66 R49.htm IDEA: XBRL DOCUMENT v3.24.0.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2023
Income Tax Disclosure [Abstract]  
Schedule of pretax income and income tax provision (benefit) for continuing operations The income tax provision was as follows:
Year Ended December 31,
(In millions)202320222021
Components of income tax provision (benefit):
Current:
Federal$913 $802 $378 
State148 175 138 
Foreign204 132 109 
1,265 1,109 625 
Deferred:
Federal(380)(339)(186)
State(12)(84)(106)
Foreign(119)(135)30 
(511)(558)(262)
Income tax provision $754 $551 $363 
Reconciliation of statutory federal income tax rate to effective income tax rate
A reconciliation of the statutory federal income tax rate to the Company’s effective income tax rate is as follows:
Year Ended December 31,
202320222021
Statutory federal income tax rate21.0 %21.0 %21.0 %
State income taxes, net of federal effect2.8 %2.5 %1.6 %
Foreign tax law changes (1)
— %— %8.0 %
Foreign derived intangibles income deduction(0.4)%(0.9)%(3.1)%
Excess tax benefit from share-based awards(0.8)%(0.8)%(2.2)%
Sale of businesses and subsidiary restructuring(1.3)%(2.2)%(2.1)%
Unrecognized tax benefits(0.2)%(0.5)%(2.7)%
Nondeductible executive compensation0.2 %0.4 %0.7 %
Transferable federal tax credits (2)
(1.4)%— %— %
Valuation allowance(0.6)%(0.5)%(1.3)%
Other, net— %(0.1)%1.9 %
Effective income tax rate19.3 %18.9 %21.8 %
(1)     Foreign tax law changes during the year ended December 31, 2021 included $134 million of income tax expense attributed to the revaluation of certain net deferred tax liabilities in connection with enacted corporate income tax rate changes in foreign countries. In 2021, the enacted tax rate in the United Kingdom increased from 19% to 25% starting in 2023, and the tax rate in Argentina increased from 25% to 35%.
(2)     Pursuant to provisions under the Inflation Reduction Act, the Company purchased transferable federal tax credits during 2023 from various counterparties. Such federal tax credits were purchased at negotiated discounts, resulting in an income tax benefit recorded during the year ended December 31, 2023. Receivables associated with transferable federal tax credits are recorded within prepaid expenses and other current assets, and amounts owed to counterparties for the purchased credits are recorded within accounts payable and accrued expenses within the consolidated balance sheet at December 31, 2023.
Schedule of deferred tax assets and liabilities
Significant components of deferred tax assets and liabilities consisted of the following:
December 31,
(In millions)20232022
Accrued expenses$193 $170 
Share-based compensation122 116 
Net operating loss and credit carry-forwards642 805 
Leasing liabilities183 170 
Other252 163 
Subtotal1,392 1,424 
Valuation allowance(467)(620)
Total deferred tax assets925 804 
Capitalized software development costs(331)(481)
Intangible assets(2,047)(2,319)
Property and equipment(341)(308)
Capitalized commissions(112)(106)
Investments in joint ventures(562)(597)
Leasing right-of-use assets(144)(134)
Other(386)(405)
Total deferred tax liabilities(3,923)(4,350)
Total$(2,998)$(3,546)
Deferred tax assets and liabilities are reported in the consolidated balance sheets as follows:
December 31,
(In millions)20232022
Noncurrent assets$80 $56 
Noncurrent liabilities(3,078)(3,602)
Total$(2,998)$(3,546)
Schedule of operating loss carryforwards and general business credit carryforwards
The following table presents the amounts of federal, state and foreign net operating loss carryforwards and foreign tax credit carryforwards:
December 31,
(In millions)20232022
Net operating loss carryforwards: (1)
   Federal$86 $214 
   State 3,074 2,810 
   Foreign 1,880 2,373 
Foreign tax credit carryforwards16 17 
(1)At December 31, 2023, the Company had federal net operating loss carryforwards of $86 million, most of which do not expire, state net operating loss carryforwards of $3.1 billion, most of which expire in 2024 through 2043, and foreign net operating loss carryforwards of $1.9 billion, of which $162 million expire in 2024 through 2043, and the remainder of which do not expire.
Schedule of operating loss carryforwards and general business credit carryforwards
The following table presents the amounts of federal, state and foreign net operating loss carryforwards and foreign tax credit carryforwards:
December 31,
(In millions)20232022
Net operating loss carryforwards: (1)
   Federal$86 $214 
   State 3,074 2,810 
   Foreign 1,880 2,373 
Foreign tax credit carryforwards16 17 
(1)At December 31, 2023, the Company had federal net operating loss carryforwards of $86 million, most of which do not expire, state net operating loss carryforwards of $3.1 billion, most of which expire in 2024 through 2043, and foreign net operating loss carryforwards of $1.9 billion, of which $162 million expire in 2024 through 2043, and the remainder of which do not expire.
Schedule of unrecognized tax benefits
Unrecognized tax benefits were as follows:
December 31,
(In millions)202320222021
Unrecognized tax benefits - Beginning of year$96 $124 $171 
Increases for tax positions taken during the current year16 
Increases for tax positions taken in prior years— 
Decreases for tax positions taken in prior years(10)(18)(41)
Decreases for settlements(3)(2)(1)
Lapse of the statute of limitations(9)(11)(26)
Unrecognized tax benefits - End of year$84 $96 $124